The US Food and Drug Administration (FDA) is warning healthcare providers about potential hazards from interactions between implanted programmable cerebrospinal fluid (CSF) shunts and hearing implants ...
Custom Safety Update image Individuals with an implantable programmable cerebrospinal fluid shunt are at risk for unintended changes to valve settings through exposure to magnetic fields present in ...
Cerebrospinal fluid (CSF) shunting improved walking speed, gait, and balance in older adults with idiopathic normal-pressure hydrocephalus, the PENS trial showed. At 3 months, gait velocity increased ...
A routine shunt surgery improves clinical care for people with hydrocephalus. Nearly half have Alzheimer's pathology, offering a natural model of LOAD. Every week, neurosurgeons supply ...
image: This is a summary of treatment of an infant with hydrocephalus-related extreme macrocephaly. The uppermost image shows the infant with gross macrocephaly before surgery. The sutures are widely ...
The developers of a minimally invasive implant for treating hydrocephalus have raised $43.9 million to help launch first-in-human clinical testing. Sometimes referred to as water on the brain, ...
The syndrome of idiopathic normal pressure hydrocephalus (INPH) is characterized by ventriculomegaly in the absence of raised intracranial pressure and presents as the clinical triad of gait ...
Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of ...
Cerebrospinal fluid shunting improved walking speed, gait, and balance in older adults with idiopathic normal-pressure hydrocephalus. An open-shunt valve setting led to no significant improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results